Journal of Clinical Nephrology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Anthony Jevnikar Author

Clinical Nephrology 2019: Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival

Departments of Nephrology and Hematology, London Health Sciences Center and University of Western Ontario, London, Ontario, Canada


Dr. Anthony Jevnikar is the Co-Director of the Multi-Organ Transplant Program, Director and Founder of the Matthew Mailing Centre for Translational Transplant Studies at the London Health Sciences Centre. He is a transplant nephrologist and Professor in the Departments of Medicine, Microbiology and Immunology, and Surgery at the Schulich School of Medicine & Dentistry. We had the opportunity to speak with Dr. Jevnikar about the recent development in Nova Scotia about a presumed consent legislation for organ and tissue donation. We also had the chance to discuss his leadership in the field of transplantation.

Subjects of specialization: Transplanting kidneys, cytomegalovirus (CMV) diseases, chronic allograft, Cytomegalovirus (CMV)-seronegative nephropathy, dialysis

Google Scholar
Research Gate
Get the App